Vyvanse (Lisdexamfetamine)

Overview

Vyvanse, the brand name for lisdexamfetamine dimesylate, is a central nervous system (CNS) stimulant medication approved by the FDA for treating attention deficit hyperactivity disorder (ADHD) in children over age 6 and adults, as well as moderate to severe binge eating disorder in adults¹. Lisdexamfetamine is classified as a prodrug, meaning it is inactive until your body metabolizes it¹. The medication was first approved by the FDA in April 2008 and represents the first chemically formulated prodrug stimulant⁵. Vyvanse was subsequently approved by Health Canada in February 2009⁵. This medication has become an important treatment option for individuals struggling with attention regulation and impulse control issues.

Forms and Variations

Vyvanse is available in multiple formulations to accommodate different patient needs and preferences⁶:

• Capsules - The standard oral form containing the medication in powder form
• Chewable tablets - An alternative form that can be substituted for capsules at the same dosage strength
• Oral solution - A liquid formulation administered using an oral syringe, particularly useful for patients who have difficulty swallowing capsules or tablets

The oral solution form is administered by tilting the head slightly upward, placing the oral syringe into the mouth toward the cheek, and slowly pushing the plunger down⁶. All formulations contain the same active ingredient and work identically in the body, allowing patients to choose the form that best suits their preferences and lifestyle.

Dosage and Administration

Vyvanse dosing is individualized based on patient response and tolerance, with treatment typically beginning at a lower dose and adjusted as needed⁶. The medication should be taken once daily, and patients must take at least one capsule or chewable tablet per day as the minimum dose⁶. The effects of Vyvanse generally begin within 90 minutes of administration and last for up to 14 hours⁴. For optimal results, Vyvanse should be taken as part of a comprehensive treatment program that includes social, educational, and psychological interventions⁶. It is important to take the medication consistently as prescribed by your healthcare provider, as irregular use may reduce its effectiveness in managing ADHD symptoms or binge eating episodes.

Scientific Research and Mechanism of Action

Vyvanse works through a unique mechanism that begins in the digestive system. When you take Vyvanse, your digestive system converts it into dextroamphetamine, a chemical compound that affects neurotransmitter levels in the brain¹. The dextroamphetamine is released gradually into the bloodstream, providing sustained therapeutic effects¹. Specifically, lisdexamfetamine works by blocking dopamine and norepinephrine reuptake and increasing their levels in the extraneuronal space⁵.

These neurotransmitters—dopamine and norepinephrine—are crucial for managing attention, concentration, and impulse control¹. By increasing the activity of these neurotransmitters, Vyvanse helps improve focus, alertness, and executive functioning while reducing hyperactivity and impulsivity¹. Clinical research has demonstrated the medication"s effectiveness: in two identically designed phase 3 clinical trials involving 724 adults with moderate-to-severe binge eating disorder, treatment with lisdexamfetamine was significantly superior to placebo at decreasing binge-eating days weekly compared with baseline². Patients receiving lisdexamfetamine also showed greater improvements across key secondary outcomes, including higher proportions achieving 4-week binge cessation and greater reductions in obsessive-compulsive symptoms related to binge eating².

Benefits and Potential Uses

ADHD Management: Vyvanse reduces hyperactivity and impulsivity, common symptoms of ADHD, helping people manage their impulses and control their behavior¹. It decreases restlessness, impulsivity, and fidgetiness, allowing individuals to focus on tasks and activities, interact more calmly with others, and exercise better self-control¹. Many people report feeling more organized, focused, and in control of their lives when taking Vyvanse¹. The medication may improve performance at school or work, strengthen relationships with family and peers, and increase satisfaction with daily life¹. Vyvanse may also help people with ADHD maintain stable and predictable routines¹.

Binge Eating Disorder: Vyvanse became the first FDA-approved medication specifically for treating moderate to severe binge eating disorder in adults on January 30, 2015². The FDA granted lisdexamfetamine priority review based on its potential to provide significant improvement over available therapies for this serious condition². Clinical evidence demonstrates that Vyvanse effectively reduces the frequency and severity of binge eating episodes, helping patients regain control over their eating behaviors.

Side Effects and Risks

Most people tolerate Vyvanse well, though some side effects may occur, particularly when first starting the medication¹. Common side effects include decreased or loss of appetite, anxiety, weight loss, diarrhea, dizziness, dry mouth, irritability, trouble sleeping, nausea, stomach pain, and vomiting³. For patients taking Vyvanse specifically for binge eating disorder, common side effects include dry mouth, trouble sleeping, decreased appetite, increased heart rate, constipation, feeling jittery, and anxiety³.

Serious side effects, though less common, require immediate medical attention and include breathing problems or wheezing, racing heart, fever or general ill feeling, swollen lymph nodes, and swelling of the face, lips, mouth, tongue, or throat³. Additional serious symptoms include trouble swallowing or throat tightness, itching, skin rash, or pale red bumps on the skin called hives³. Stimulants are associated with peripheral vasculopathy, including Raynaud"s phenomenon, so careful observation for digital changes is necessary during treatment². There is also a risk of less common but more severe side effects, especially in people with other health conditions¹.

Interactions and Precautions

Vyvanse has several important drug interactions that must be considered before starting treatment. Do not take Vyvanse if you are currently taking or have taken within the past 2 weeks a monoamine oxidase inhibitor (MAOI), which is a medicine usually used for depression or Parkinson"s disease, including the medicines linezolid and methylene blue³. Additionally, caution is advised when combining Vyvanse with selective serotonin reuptake inhibitors (SSRIs), which are commonly used for anxiety and depression³. Serotonin norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, triptans used for migraine headaches, and lithium used for certain mental health conditions also require careful consideration and medical supervision when used with Vyvanse³.

Pregnancy Considerations: Based on animal data, lisdexamfetamine may cause fetal harm and should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus². Pregnant women or those planning to become pregnant should discuss the risks and benefits with their healthcare provider. Vyvanse is available only with a doctor"s prescription, and all patients must receive a medication guide that informs them about the drug"s appropriate use and potential risks².

Impact on Biomarkers

Vyvanse affects several physiological markers that healthcare providers may monitor during treatment. The medication can increase heart rate, which is why cardiovascular monitoring may be recommended, particularly in patients with pre-existing heart conditions³. Appetite suppression is a common effect, which may result in decreased caloric intake and potential weight loss³. For patients with binge eating disorder, the primary biomarker of interest is the reduction in binge eating episodes and the frequency of binge days per week, which clinical trials have demonstrated improves significantly with treatment². Blood pressure may also be affected by stimulant medications, making regular monitoring advisable during treatment initiation and dose adjustments.

Overdose and Toxicity

While specific overdose data for Vyvanse is limited in the provided sources, stimulant overdose can result in serious complications. Symptoms of excessive stimulant exposure may include severe anxiety, rapid or irregular heartbeat, elevated blood pressure, hyperthermia (elevated body temperature), and potentially seizures. There is no specific antidote for lisdexamfetamine overdose; treatment is supportive and symptomatic. If you suspect an overdose, seek emergency medical attention immediately. To prevent overdose, always take Vyvanse exactly as prescribed by your healthcare provider and store the medication securely, especially if there are children in the home. Never increase your dose without medical supervision, and inform your doctor if you feel the medication is not working effectively at your current dose.

Disclaimer

The information provided in this document is for educational purposes only and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.